2021 Partners

Conagen - Expertise Partner

Expertise Partner:

Conagen is making the impossible possible.
Our scientists and engineers use the latest synthetic biology tools to develop sustainable, nature-based molecules bio-manufactured into the highest quality products available. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. For more information, visit www.conagen.com

arranta bio

Innovation Partner:

Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. With a ten-year legacy as Captozyme, Arranta’s has a proven track record with 125 species in process development and contract manufacturing of live biopharmaceuticals, and provides the resources necessary to help clients to deliver promising new microbiome therapies to meet the needs of patients.


Quay Pharma

Virtual Exhibitor:

Quay Pharmaceuticals is a privately owned CDMO working from FDA and MHRA inspected facilities. We are licenced to formulate and manufacture finished dosage forms for live biotherapeutics as well as small large molecules. In the live biotherapeutic space we work with consortia and single strain for drug delivery in oral, pessary and topical formats. Working as part of your team we rapidly and effectively bring products through development to First in Human studies to deliver success. We have worked on more than 50 plus strains from Phase I to Phase III projects and we are currently preparing for Commercial project.


biose Industries

Virtual Exhibitor:

Biose Industrie is the world leading fully integrated CDMO for LBP process development and production of both drug substance & Drug Product. We have nearly 70 years’ experience of developing and producing bacteria under full GMP pharma conditions. We’ve produced many strict anaerobes in large industrial volumes for later stage clinical trials and currently service a large share of the LBP market place upon the back of the excellent results we have offered for our clients.